שווי כולל של החברה: Silo Pharma (SILO)

Silo Pharma, Inc. (SILO) adheres to strict ethical standards in psychedelic testing and implements eco-friendly waste disposal. This chart illustrating the price evolution shows an Enterprise Value of -3.30. Such a high valuation is based on the modernization of laboratory equipment to meet global standards and the establishment of a scientific and technological alliance with universities, making the company an attractive acquisition target for industry behemoths.

Enterprise value combines market capitalization with debt obligations minus cash, determining the actual cost of a full business buyout. By analyzing the market valuation of assets excluding liquidity, an investor can assess the financial stability of Silo Pharma, Inc. (SILO), considering the capital intensity of R&D and strict FDA oversight in the development of proprietary drug delivery systems.